Forbes July 19, 2024
As an endocrinologist who has cared for patients with diabetes and obesity for over a decade, it’s incredibly encouraging to see the increasing attention and investment in the field of diabetes management.
Our field is energized by the progress we’ve seen over the past several years. And as I reflect on my conversations with health leaders, researchers and scientists at the American Diabetes Association (ADA) Scientific Sessions recently, I think change in our industry is only accelerating.
The rising demand for GLP-1s, advancements in research and technology and the increasing focus on health disparities are shaping the future of diabetes management in profound ways, and uncovering challenges for employers and health plans. As these developments continue to shape the future...
Today's Sponsors
Today's Sponsor